To compare two rat ovary cryopreservation techniques (vitrification vs. slow freezing) and two postmenopausal stages (early vs. late) with regard to graft take.
Introduction
With the advent of new therapies against chronic degenerative diseases, especially neoplasia, the life expectancy of many young patients has been extended. Ovarian function may be lost prematurely as a result of treatment for neoplasia (depending on the age of patient), the chemotherapy regimen and the irradiation levels used. In addition, even though ovulation resumes after oncological treatment, fertility may have been compromised.
For such patients, the maintenance of ovarian function is often a priority, with direct implications on future quality of life¹.
Thus, many women seek medical care in an attempt to postpone the menopause and its complications and maintain ovarian function as long as possible.
The menopause can be a very distressing and debilitating period, with a range of accompanying manifestations, including vasomotor symptoms, insomnia, headache, genito-urinary disorders, fluctuations in libido, bone-joint changes and osteoporosis².
In a recently published review, chances of spontaneous gestation were estimated at 28% and 5% for women under 20 and over 25 years of age, respectively, following treatment for cancer with radiotherapy and chemotherapy³.
Cryopreservation is an experimental fertility preservation technique involving the surgical removal and cryopreservation of the ovaries of mostly young women prior to chemotherapy in order to avoid exposure to systemic gonadotoxic compounds. Following treatment, provided the patient is believed to be disease-free, the ovaries may be reimplanted. Though still in the experimental stage, cryopreservation is considered a promising alternative for the recovery of fertility [4] [5] .
The recovery of ovarian function by way of reimplantation of cryopreserved tissue has been successfully accomplished in both animals and humans. However, due to the small number of patients submitted to this procedure so far, the technique has not been fully standardized [6] [7] .
Several animal models have been designed to evaluate compounds capable of improving the techniques and outcomes of cryopreservation. Over time, a number of different compounds have been used in the cryopreservation of reproductive cells.
Thus, several studies were conducted in the 1990s evaluating the cryoprotective efficiency of DMSO, ethylene glycol, propylene glycol and even glycerol (used since 1949) 7 .
Initially, most research was focused on the cryopreservation of spermatozoa. Already in 1951, the first calf was born using frozen bull sperm. after orthotopic transplantation of frozen/thawed half ovaries, demonstrating that ovarian tissue retrieved post-mortem was viable even after a period of storage at low temperatures 13 .
In Proper training in the techniques of cryopreservation and autotransplantation in animals is indispensable for surgeons who wish to offer this treatment option for patients in whom ovarian function may be compromised by radio and chemotherapy.
Methods
The experimental protocols were reviewed and approved 
Ovarian tissue
Following excision, the ovaries (~2 mm 3 ) were dissected free of fat and mesentery. One of the ovaries was submitted to histological analysis; the other was cryopreserved.
Design of the experiment
Stage I: Thirty-three Wistar rats were submitted to bilateral oophorectomy. One ovary was immediately submitted to histological analysis, while the other was cryopreserved by slow freezing (n=10) or vitrification (n=23) 7, 16 .Two animals from the slow freezing group and five animals from the vitrification group died.
The controls included six animals from the vitrification group and two from the slow-freezing group. The latter two animals provided sufficient material for control and experimental procedures.
Stage II: The cryopreserved ovary was thawed and reimplanted in the greater omentum one week after oophorectomy (early menopause) (Group A, n=7; 3 vitrified and 4 slow-frozen) or one month after oophorectomy (late menopause) (Group B, n=13; 9 vitrified and 4 slow-frozen).
Stage III: One month after ovary reimplantation, the animals were euthanized, the graft was excised and graft take was evaluated. al. 16 Prior to reimplantation, the vials containing the samples were removed from liquid nitrogen storage and exposed to room temperature for one minute. Then each sample was submitted to three 5-min baths in a solution containing minimal essential medium + 10% fetal calf serum and decreasing concentrations of sucrose (0.5, 0.25 and 0.0 M), using a protocol adapted from
Vitrification and warming procedures
Lunardiet al.
7
.
Slow freezing
The procedure was carried out according to the protocol described by Gosden et al. 
Histology
Samples of the ovaries were submitted to histological analysis at three different moments: i) upon oophorectomy, when the ovaries were presumed to have a normal production of follicles, ii) upon thawing, in order to compare the outcome of the two freezing techniques (slow freezing and vitrification), and iii) upon euthanasia, in order to evaluate graft take one month after ovary reimplantation in both early (one week) and late (one month) postmenopausal rats 18 .
Statistical analysis
The study variables were dichotomous (presence/absence).
Using the software GraphPadPrism 5.0, findings were submitted to Fisher´s exact test and expressed as absolute frequencies and percentages. The level of statistical significance was set at 5% (p<0.05).
Results

Slow freezing
Two of the 10 rats which received an ovarian graft cryopreserved by slow freezing died (mortality: 20%). The graft was evaluated for viability prior to reimplantation in two (25%) of the eight surviving animals. In one of these (50%), primordial follicles and corpus luteum were observed, matching findings in the literature (42%).
Upon euthanasia, no ovarian graft was found in five (62.5%) animals.
In the remaining three animals (38.5%), the graft had taken. One of these (12.8%) presented atretic follicles while 2 (25.6%) presented primordial follicles and corpus luteum ( animals, just inflammatory/scar tissue and/or fibrosis. In the other six animals (50%), the graft had taken (Figure 1 ). 
TABLE1 -Histological findings following reimplantation of ovarian tissue in 20 female Wistar rats.
Legend: CL = corpus luteum; AF = atretic follicles; PF = primordial follicles. presented primordial follicles and corpus luteum (Figures 2 and 3 ).
Ovary cryopreservation and reimplantation
ANIMAL
Of the 20 animals in the final sample, seven belonged to Group A (early postmenopause) and 13 belonged to Group B (late menopause). In the latter group, nine ovaries were vitrified, followed by five (55.5%) successful reimplantations, while four ovaries were slow-frozen, followed by only one successful reimplantation (25%). Nevertheless, the difference between the techniques did not reach statistical significance (p=0.559).In Group A, three ovaries were vitrified, followed by one (33.3%) successful reimplantation, while four ovaries were slow-frozen, with no successful reimplantation (0%). Again, the difference was not significant (p=0.429). However, when the two postmenopausal stages (early vs. late) were compared with regard to graft take, a statistically significant difference emerged: the graft take rate was 9.3 times higher in late postmenopausal rats (61.5%) than in early postmenopausal rats (14.3%) (p=0.043).
Discussion
Despite being a promising technique, ovarian tissue cryopreservation has only resulted in about 20 human live births so far. Much research is needed to improve success rates for both slow-frozen and vitrified tissue and to ensure the health of children born from such treatments. In one study, for example, 27 patients received similar treatments, eight had evidence of antral follicle growth and oocytes were retrieved, but only one gave birth 19 .
In the current study, we used a rat model to compare two cryopreservation techniques (slow freezing vs. vitrification) and to evaluate the influence of postmenopausal status (early vs. late) on graft take. Our findings raise questions about the ideal moment of ovary reimplantation in relation to hormonal metabolism. In other words, the time of absence of ovarian function appears to determine how the organism reacts to reimplantation.
Vitrification resulted in a higher graft take rate than slow freezing (50% vs. 38.5%) and follicles were present in all specimens. The success rate of slow freezing was similar to the rates reported in the literature: in vitro studies suggest that vitrification of ovarian tissue may be an improvement over the 70% oocyte viability loss from slow freezing 7 .
During the 2009 World Congress on Fertility Preservation in Belgium, a list was given of the advantages and disadvantages of vitrification as applied to human ovary cryopreservation.
The advantages included i) excellent survival of ovarian stroma and blood vessels, ii) the technique is quick to perform, iii) no sophisticated equipment is needed, iv) the technique is clinically feasible, and v) excellent survival in tissue culture. On the other hand, the disadvantages included i) no live births reported until FIGURE 2 -Atretic follicles after reimplantation (Magnification: x200 and x400). vs. Group A=16.7%), but the difference between the groups with regard to take rate was not statistically significant (p=0.080).
Slow freezing vs. vitrification
Upon thawing, the ovarian tissue was preserved in 50% of slow-frozen specimens versus 100% of vitrified specimens; however, the difference was not statistically significant (p=0.400).
Vitrification resulted in a higher graft take rate than slow freezing (50% vs. 37.5%), but the difference was not statistically significant (p=0.400).
Postmenopausal stage
Six of the seven deaths mentioned in the section describing the designof the study involved animals in the early postmenopausal stage (Group A). The high mortality in this group (6/13; 46%) when compared to that of Group B (1/13; 7%) may be explained by surgical stress, considering the short period elapsed (one week) between oophorectomy and reimplantation.
Thus, mortality was not related to the cryopreservation technique employed but to the timing of the two surgical interventions.
2009, ii) the technique requires a considerable level of training, iii)
the technique is very sensitive to concentrations, osmolarities and swiftness of procedure, and iv) ovarian tissues may be damaged by toxicity if the surgeon is not properly trained. However, recent studies describing human births following ovarian cryopreservation and reimplantation, along with the findings of the current study, indicate that the technique has been mastered despite its complexity.
The subject of rat postmenopausal status has been little discussed in the literature. In our experiment, a significant difference was observed between early and late postmenopausal rats (Groups A and B) with regard to graft take rates. This finding may be interpreted in light of two important studies, one by López-Grueso et al. 20 and one by Ahmed et al. 18 .
The first study looked at oxidative stress and estrogen 
Conclusions
Both vitrification and slow freezing were feasible though the former yielded better results when the time of reimplantation was taken into account. Regardless of the time of cryopreservation, rat ovary reimplantation is more likely to be successful in the late postmenopausal stage.
